323
260193226014562120181
PŘEHLEDOVÝ852207016974156235334409485586692777867
ČLÁNEK1757207016989163260360438521
Ces8507936014570127174
Urol10497936014578115180208
2020;12827936014562121178237261
24(4):15697936014561118151208238260
247–26018557936014561118174228283341402
25.850896013356112133
Kudlackova1007896013359118180205258306357416467520
S,155189601335476
Kral165189601336097150175
M,1850896013388112
Koranda1986896013360118154207268329382
P,239289601335868
Student248489601335488148210265325360
V.286889601336278
18-F2971898013154100134186
cholin3181898013150107166189210268
PET3473898013156104158
CT3656898013162117
v3797898013150
primodiagnostice387289801316193115204262323344393452510568608643665713764
karcinomu466089801314798129176198255313403460
pro‑514589801316193149184
staty.850104801314176125157209222
Ces10961048013163114154
Urol12741048013169100156180
2016;14781048013153105153199217
20(1):17191048013153105134181201218
57–64.19611048013154104153210265283
26.8501196013356110133
Zettinig10051196013361114151189214274299360
O,1387119601337695
Shah15041196013354115167227
A,1753119601336792
Hennersperger18671196013371127188248303339383444500536596651687
C,2576119601336488
et2685119601335692
al.2799119601335378100
Multimodal29221198013186143165198220309368428477499
image‑guided34451198013121110159218271306368425447506559619
prostate4086119801316193149189224274306357
fusion4467119801312786125147204263
biopsy4752119801316184141202242291
based50651198013161111151204264
on8501348013159117
automatic9881348013150107141197287335368390438
deformable14471348013160113141198230320369429452505
registration.1976134801312981141163202237268318350373430489508
International2508134801312078110161192251300332354411470519541
Journal3073134801313594152183242290313
of3407134801315887
Computer35151348013163119209268326360411442
Assisted39791348013164106146167206241292352
Radiology43521348013156105165187244267325386434
and48081348013149107167
Surgery49961348013151108139197250281333
2015;8501498013154105153198212
10(12):10871498013153100129177221247264
1997–2007.1375149801315499152202251298350405454461
27.8501646013356108119
Storz989164601335387145181229
E,1237164601335476
Shah13321646013354113165225
A,1576164601336791
Zettinig16861646013361114150188212272296357
O,2062164601337594
et2176164601335490
al.2285164601335378100
21724051648013153100143
PSMA‑PET/MRI‑guided25681648013155104186250281337385438469552606629662723779801859912971
transrectal3563164801313061110168206237288337372421443
fusion4030164801312583122142199257
biopsy4307164801316083140199239287
for4618164801312581113
the4755164801312987139
detection49141648013159112144195244279301358416
of850179801315987
prostate961179801316193149189224273306357
cancer.1342179801314998156205256287301
European16671798013151107138195255309357415
Urology2106179801316999156179237297346
Supplements24761798013151108167227251303392446503535577
2015;30771798013154105153198212
14:33141798013153100117
e217.34551798013153105152196203
28.8501946013357112135
Krimphove10081946013368105131222284345406457511
M,15501946013389113
Theissen16861946013363125180206248291346407
L,2117194601335983
Cole22311946013364123149204
A,2466194601336893
et25821946013363100
al.2705194601336186109
Performance28391948013164114146178235267358407465513565
and34281948013158116176
Impact36281948013131120180230279315
of3968194801316695
Prostate4087194801316394151191226275308359
Specific44701948013159118173222244270297346
Membrane48481948013186139228288320371429482
Antigen‑Based8502098013164122154176235288346380436486526579639
Diagnostics1514209801317194142201259317357392414462504
in2042209801312381
the2147209801313593146
Management23172098013186135193242301354443496554586
of2927209801315987
Men30392098013186139197
with32602098013180102136194
Biochemical3478209801315678136185243296385407455505527
Recurrence40302098013155108158215247279330388437488
of4542209801315987
Prostate4654209801315586142182217266298349
Cancer50282098013163113170219270301
and8502248013150108167
Its104122480131235798
Role11632248013156114137190
in1377224801312381
Salvage14822248013151101123172222281334
Lymph1840224801314992182242300
Node21642248013171129189242
Dissection.2430224801317194133173226275311334391450469
The29232248013151111164
World31112248013190145177200259
Journal3395224801313896154185244293315
of3734224801315887
Men’s38452248013186139197214251
Health41202248013169122170193226284
2020;44282248013154105155206225
38(1):46772248013153105133181201218
32–47.49192248013154103154211259266
29.8502396013356110128
Rauscher10022396013359111169211259318372407
I,1431239601332850
Düwel15052396013373133212265290
C,1819239601336487
Wirtz19302396013393118152190238
M,21922396013388111
et2327239601335591
al.244223960133537798
Value25652398013156102123179231
of2820239801315986
111In‑prostate‑specific2931239801315493133148204236296327383422455503534584618657715768817837862889936
membrane38922398013190142230289320368425477
antigen43942398013150106137158216268325
(PSMA)-radio‑4742239801313184132215278304337369417476497553587
guided8502548013160116137195246306
surgery1174254801314197127184236266317
for1514254801312480111
salvage1644254801314190111159208266318
lymphadenectomy1985254801311966155214271319377429486538586622676765810
in2818254801311975
recurrent2916254801312979128184214245296352383
prostate3318254801316192147186219268299349
cancer:3686254801314997154202251282300
correlation40052548013149104135166217238286317338394452
with44762548013179100133190
histopathology4684254801315980118151206265314345402459481538597645
and8502698013150107165
clinical103726980131497090147167214263284
follow‑up.1344269801312884106127183261293351409426
BJU1792269801315591157
International1972269801312279110160190248295326347404461509530
2017;25242698013154104151193205
120(1):2751269801315497148175222241257
40–47.30292698013154108165220267273
30.8502846013356111133
Maurer10032846013388141200235290325
T,1348284601335470
Robu14382846013359119181241
S,1699284601335476
Schottelius17952846013354103163223258297350376401460503
M,23172846013389113
et2449284601335591
al.2560284601335378101
99mTechnetium‑based268128480131541071962402863353924505035365586147037367978478879401000
Prostate‑specific3701284801315585142182216265297348383423482536585607633659707
Membrane44292848013185138227287318368426479
Antigen–49282848013164122154176234287345401
radioguided850299801313282142164221282339361420473533
Surgery14072998013151108139197250281333
in1764299801312381
Recurrent18692998013155108158215247279330388420
Prostate2313299801315586142182217267299350
Cancer.26872998013162112170219269301315
European30262998013151107138194255309357414
Urology3465299801316899156179237297346
2019;38352998013153105153198216
75(4):40752998013154103129178203220
659–666.43192998013154105154211268322376395
31.8503146013356106123
Zhang9933146013361120173233294
Q,1307314601337699
Helfand14263146013371127153184238298360
BT,18063146013359114129
Carneiro19553146013364117152213268293328388
BA,23633146013359125149
et2532314601335591
al.2643314601335378101
Efficacy2764314801315177105133182231280331
Against31153148013164122171193250290324
Human34603148013169126215264321
Prostate3802314801315585142182216266298349
Cancer41713148013163112170219270301
by44923148013161108
Prostate‑specific4620314801315686142182217266299349384424483537586608634661709
Membrane8503298013186139228287319369427480
Antigen‑specific,13523298013165123154177236289346380420479533583605631657706724
Transforming2098329801315176126184223253310342432454511570
Growth26903298013169101158236273331
Factor‑β3043329801315195143180236268296357
Insensitive3424329801312178118171229268289323345394446
Genetically38923298013169123180233267289337387409431479
Targeted4393329801315192123181234267318379
CD8+47943298013162132185250
T‑cells5066329801315178129180202224263
Derived8503448013171125156179228280340
from1214344801312962118208
Patients14453448013156104136158211268300342
with18113448013179102135193
Metastatic20283448013185138172221261295345377399447
Castrate‑resistant24993448013163113152187219269301352386419471511532571606655713745
Disease.3268344801317193132185233273326343
European36353448013151107138194255309357414
Urology40733448013169100156179237298346
2018;44433448013153105153199216
73(5):46833448013154105132182209226
648–652.49333448013153109164220277328378396
32.8503596013356107130
Lamb9983596013352105194255
AD,12723596013366137156
Bryant1447359601335993147199259293
RJ,17583596013359102122
Mills18993596013387112137161202
IG,2124359601332292115
Hamdy22583596013371123212273324
FC.26013596013352114138
First2759359801315071101141175
Report29533598013155107166224255291
of3264359801315785
Prostate‑specific3368359801315585140179213262293343377416474527575597622648696
Membrane40833598013184137224283314363419471
Antigen–targeted45743598013163120151173231282339394426475506562614646696756
Immunotherapy8503748013123112201258316374407465518549599659706
in1580374801312380
Prostate1684374801315686143183217267299350
Cancer:20583748013163113170219270301321
The24033748013151111164
Future25913748013151106140197229280
is2895374801312362
Bright.2981374801315687110169227259278
European32833748013151106138194254308356414
Urology37213748013169100157180238298346
2018;40913748013154106153200217
73(5):43323748013154106132183209226
653–655.45823748013154105155210267318367384
33.8503896013356110131
Roach10043896013366126179228288
PJ,1315389601336597118
Francis1456389601336093146206255280322
R,1802389601336590
Emmett19153896013361151242298334372
L,2311389601335882
et2416389601336198
al.2537389601335985107
The26683898013158118171
Impact28633898013130118178228277313
of3200389801316593
68Ga‑PSMA33173898013161115183232265322371455519
PET/CT38603898013162111164196255310
on41943898013165123
Management43483898013186135192241301354443496554585
Intent4958389801312987119170228260
in5242389801312987
Prostate850404801315586142182217266299350
Cancer:12214048013163112170219270301321
Results15634048013156109149205228261302
of1887404801315887
an19954048013150108
Australian21244048013164121160194226276298320368426
Prospective2571404801315586142182242296345381403453504
Multicenter30974048013185143165198220268319377409460491
Study.3610404801315182140199247261
Journal3895404801313594152183242291313
of4229404801315987
Nuclear43374048013171128177199251300331
Medicine46894048013186139199221269291349402
2018;51124048013154105153199217
59(1):8504198013154102130178198215
82–88.10894198013154104156211265284
34.8504346013356111133
Han10014346013371123182
S,1202434601335475
Woo12964346013392148208
S,1523434601335475
Kim1617434601335985174
YJ,1810434601335991112
Suh19414346013353112171
CH.21314346013363132155
Impact23104348013119106165214261297
of2626434801315885
68Ga‑PSMA27314348013153106172221254309358440503
PET32534348013155102155
on34274348013158116
the3566434801312986139
Management37244348013184133189237295347435487544575
of4318434801315886
Patients44234348013155102133155206263294335
with47774348013179101133190
Prostate4986434801315585140179213262293343
Cancer:8504498013163112170219270301321
A11954498013164
Systematic1283449801315196137171222311360392414463
Review17704498013155108157180232311
and21054498013150108167
Meta‑analysis.22964498013186139172222255304362410433481521543581601
European29214498013151107138194255309357415
Urology3360449801316899156179237297346
2018;37304498013153105153199216
74(2):3970449801315499128179206222
179–190.4216449801315498148205251296351369